|1.||Stempien-Otero, April: 1 article (02/2015)|
|2.||Moussavi-Harami, Farid: 1 article (02/2015)|
|3.||Cheng, Yuanhua: 1 article (02/2015)|
|4.||Regnier, Michael: 1 article (02/2015)|
|5.||Razumova, Maria V: 1 article (02/2015)|
|6.||Racca, Alice W: 1 article (02/2015)|
|7.||Longyear, Thomas J: 1 article (05/2014)|
|8.||Turner, Matthew A: 1 article (05/2014)|
|9.||Debold, Edward P: 1 article (05/2014)|
|10.||Lopez, Joseph: 1 article (05/2014)|
12/01/1983 - "Defibrination before nucleotide extraction of mononuclear cells from a patient with T-cell leukaemic/lymphoma treated with the ADA inhibitor deoxycoformycin enabled the demonstration of grossly raised deoxy-ATP levels relative to deoxy-ADP levels (ratio 16.1:1), associated with severe ATP depletion. "
|3.||Hepatocellular Carcinoma (Hepatoma)
10/01/2000 - "Similarly, in vitro activation of hepatoma cell lysates with 2'-deoxyadenosine 5'-triphosphate (dATP) results in the formation of the approximately 700-kd apoptosome complex, which recruits and processes caspases-3 and -7. Z-VAD.FMK [benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone], the pan-caspase inhibitor totally inhibits dATP-stimulated caspase activation but does not block the assembly of the large Apaf-1 containing apoptosome complex. "
05/01/2014 - "We sought to gain novel insight into the decrease in velocity by determining whether the depressive effect of acidosis could be altered by 1) introducing Ca(++)-sensitizing mutations into troponin (Tn) or 2) by agents that directly affect myosin function, including inorganic phosphate (Pi) and 2-deoxy-ATP (dATP) in an in vitro motility assay. "
|5.||Adenosine Triphosphate (ATP)
|6.||Adenosine Diphosphate (ADP)
|7.||benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone